COST-MINIMIZATION ANALYSIS TO TWO SURGICAL TREATMENTS OF BENIGN PROSTATIC HYPERPLASIA IN THE BRAZILIAN PRIVATE HEALTH SECTOR

被引：0
|
作者：
Rodrigues, S. [1 ]
Tortele, H. [2 ]
Conto, M. [1 ]
机构：
[1] Boston Sci, Sao Paulo, Brazil
[2] Boston Sci, Santo Andre, SP, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MT5
引用
收藏
页码：S297 / S298
页数：2
相关论文
共 50 条
  • [31] Evaluation of the Cost-Effectiveness of Surgical Treatment Options for Benign Prostatic Hyperplasia
    Wymer, Kevin M.
    Narang, Gopal
    Slade, Austen
    Sharma, Vidit
    Thao, Viengneesee
    Borah, Bijan J.
    Rivera, Marcelino
    Cheney, Scott
    Humphreys, Mitchell R.
    UROLOGY, 2023, 171 : 96 - 102
  • [32] A multilingual evaluation of current health information on the Internet for the treatments of benign prostatic hyperplasia
    Chen, Emily C.
    Manecksha, Rustom P.
    Abouassaly, Robert
    Bolton, Damien M.
    Reich, Oliver
    Lawrentschuk, Nathan
    PROSTATE INTERNATIONAL, 2014, 2 (04) : 161 - 168
  • [33] Transurethral water vapor therapy for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a cost-minimization and budget impact analysis from an Italian healthcare perspective
    Blissett, Robert S.
    Blissett, Deirdre B.
    Oselin, Martina
    Demaire, Clementine
    Woodward, Emily
    Siciliano, Michele
    Torres, Esperanza
    Franzoso, Francesco
    Comelli, Tiziana
    MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (03): : 343 - 352
  • [34] A COST-MINIMIZATION ANALYSIS OF A NEW FIXED-DOSE COMBINATION OF DUTASTERIDE AND TAMSULOSIN COMPARED TO CONCOMITANT ADMINISTRATION OF BOTH MONOTHERAPIES FOR THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA IN QUEBEC, CANADA
    Sayani, A.
    Ismaila, A.
    Posnett, J.
    Walker, A.
    Laroche, B.
    Nickel, J. C.
    Su, Z.
    VALUE IN HEALTH, 2013, 16 (03) : A182 - A182
  • [35] ANTIMICROBIAL THERAPY DISINFECTION: A STRATEGY FOR RATIONALIZATION AND COST-MINIMIZATION IN PRIVATE HEALTH SETTINGS IN CEARA
    Reis, H. P.
    Rodrigues, J. L.
    Girao, E. S.
    Pontes, L.
    Ponte, G.
    VALUE IN HEALTH, 2017, 20 (09) : A933 - A933
  • [36] A cost comparison analysis of two clinically uroselective alpha blockers in the treatment of benign prostatic hyperplasia
    Botteman, MF
    Lowe, FC
    Naslund, M
    Sollano, J
    Pashos, CL
    Litwin, M
    VALUE IN HEALTH, 2004, 7 (03) : 363 - 363
  • [37] COST-MINIMIZATION ANALYSIS AND TOTAL COST ANALYSIS FOR A WEIGHT RANGE IN CROHN'S DISEASE TREATMENT WITH ANTI-TNF BIOLOGICS UNDER BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE
    Menezes, F. G.
    Chibana, V
    VALUE IN HEALTH, 2015, 18 (07) : A670 - A670
  • [38] COST-MINIMIZATION ANALYSIS OF LANREOTIDE AUTOGEL VERSUS OCTREOTIDE LAR IN PATIENTS WITH ACROMEGALY IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Serafini, P.
    Suseda, M.
    Ortis, F.
    Mendanha, T.
    VALUE IN HEALTH, 2021, 24 : S200 - S200
  • [39] COMPARATIVE EFFICACY OF NOVEL SURGICAL TREATMENTS FOR BENIGN PROSTATIC HYPERPLASIA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Tsai, Chung-You
    Huang, Shi-Wei
    JOURNAL OF UROLOGY, 2020, 203 : E1189 - E1189
  • [40] A cost-minimization analysis of two pharmacological stressors for myocardial perfusion imaging in two different health insurance systems
    Krug, B.
    Bary, M.
    vander Borght, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S104 - S105
12345